Search for: "CFS Corporation" Results 1 - 20 of 665
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Apr 2012, 1:09 pm by Mark S. Nelson
The SEC's Division of Corporation Finance has issued CF Disclosure Guidance: Topic 5. [read post]
25 Apr 2007, 8:33 pm
Singer -- Luminex Corporation announced that it received a non-exclusive license from Johns Hopkins University with rights to use the University's patented cystic fibrosis (CF) genetic markers. [read post]
5 Oct 2022, 3:30 am by Bill Bratton
Friedman as a result emerges as the fundamental theory-giver rather than as a “but cf. [read post]
25 Mar 2020, 3:09 pm by Jonathan B. Abram
On March 25, the SEC issued CF Disclosure Guidance Topic No. 9 that provides the Division of Corporation Finance’s current views regarding disclosure and other securities law obligations that companies should consider with respect to COVID-19 and related business and market disruptions. [read post]
22 Apr 2012, 11:04 am by Securites Lawprof
The SEC posted on its website CF Disclosure Guidance: Topic No. 5 Staff Observations Regarding Disclosures of Smaller Financial Institutions, which summarizes a number of the Division of Corporation Finance's observations on Management’s Discussion and Analysis and accounting policy disclosures... [read post]
3 Nov 2009, 12:34 pm
The Division of Corporation Finance staff recently issued Shareholder Proposals, Staff Legal Bulletin No. 14E (CF), providing information regarding staff changes of position on two issues: the application of Rule 14a-8(i)(7) to proposals relating to risk; and the application of... [read post]
24 Jun 2016, 2:00 am by LindaMBeale
  Related articles Levin Statement on Scrapped CF Industries Inversion [read post]
18 Jul 2020, 7:18 am
On June 23, 2020, the Division of Corporation Finance (CF) and the Office of the Chief Accountant of the US Securities and Exchange Commission (SEC) released guidance that provides additional views on disclosure related to COVID-19, supplementing earlier guidance provided on March 25, 2020 and April 3, 2020, respectively. [read post]
30 May 2022, 9:05 pm by Paul P. Momtaz
Momtaz, Chair of Private Equity at the House of Finance at Goethe University in Frankfurt, Germany and Metzler Visiting Professor at the Wharton School at the University of Pennsylvania; Niclas Dombrowski, a PhD student at Hamburg University; Wolfgang Drobetz, Chair of Corporate Finance and Asset Management at Hamburg University, Germany; and Douglas J. [read post]
17 Nov 2011, 5:58 am
In Part One of this article, we looked at the Securities and Exchange Commission (SEC) Division of Corporation Finance's recent release - CF Disclosure Guidance: Topic No. 2 - Cybersecurity (the "Guidance"), which is intended to provide guidance to companies on whether and how to disclose the impact of the risk and cost of cybersecurity incidents (both malicious and accidental) on a company. [read post]
8 Jan 2021, 3:00 am by John Jenkins
Shortly before the Christmas holiday, the SEC’s Division of Corporation Finance issued  CF Disclosure Guidance Topic: No. 11, which provides Corp Fin’s views regarding disclosure considerations for SPACs in connection with both their IPOs & subsequent de-SPAC transactions. [read post]
30 Mar 2011, 1:22 pm
Section 1-102 of the Corporations and Associations Article is expansive and applies to every Maryland corporation and to all their corporate acts.Facts: CF, a competitor of Terra, made numerous attempts to acquire Terra through unsolicited bids. [read post]
30 Dec 2008, 2:32 am
Corp., 213 AD2d 846, 847 [1995]; see also Abrams v Donati, 66 NY2d at 953-954; cf. [read post]
4 Nov 2019, 6:12 am
On October 16, 2019, the staff of the SEC’s Division of Corporation Finance (the Division Staff) issued Staff Legal Bulletin No. 14K (CF) (SLB No. 14K), which provides additional guidance on the excludability of shareholder proposals under Exchange Act Rule 14a-8. [read post]